This study thoroughly examined POC1A expression and its implications for diagnosis, staging, prognosis, immune infiltration, tumour mutation burden (TMB), immune checkpoint profiles and drug sensitivity in order to elucidate the clinical significance of POC1A for LUAD. This evidence concerns the gene POC1A and neoplasm.